Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...
Advances in 3D spatial multiomics are changing how researchers study tissue architecture. We spoke with Stellaromics' CEO, Dr. Todd Dickinson, to learn how this approach preserves structure and ...
Stellaromics today launched Pyxatm, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch marks a ...
The launch marks a fundamental shift in spatial biology — from 2D thin-section approaches that analyze partial cell layers to true 3D analysis that preserves the native organization of cells, ...
AI in Pathology Market OverviewThe global AI in pathology market is anticipated to witness robust expansion, growing at an ...
IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' ...
Bruker Corporation (Nasdaq: BRKR) announced today significant portfolio advancements from Bruker Spatial Biology to be ...
SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- OmicInsight Corporation, an innovator in ...
A new spatial transcriptomic technology captures RNA patterns without requiring expensive imaging ...
University Health Network's Toronto General Hospital has ranked second in the world in Newsweek magazine's World's Best Hospitals 2026, marking the highest position ever achieved by a Canadian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results